VLDLR and Alzheimer disease: Additional binding partners for S2R/TMEM97 have been determined, notably the low-density lipoprotein receptor (LDLR), an interaction that has implications for lipid homeostasis and Alzheimer’s disease (AD; Riad et al., 2018).